ArticleCureus2026
A Novel Neurofibromatosis Type 1 (NF1) Frameshift Mutation Associated With Atypical Hypotensive Pheochromocytoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome associated with an increased risk of pheochromocytoma. Pheochromocytoma typically presents with hypertension and catecholamine excess; however, atypical clinical features may occur. A 58-year-old Turkish male patient with clinically diagnosed NF1 was evaluated for persistent hypotension (approximately 90/50 mmHg) without classic catecholamine-related symptoms. Biochemical testing showed isolated elevation of plasma and urinary metanephrine, while normetanephrine and other catecholamines were within reference ranges. Imaging revealed a 3.7 cm left adrenal mass with increased uptake on Gallium-68 DOTA-octreotate Positron Emission Tomography/Computed Tomography (Ga-68 DOTATATE PET/CT). The patient underwent left adrenalectomy after carefully titrated preoperative alpha-blockade due to baseline hypotension. Histopathological findings were consistent with pheochromocytoma. Genetic analysis using next-generation sequencing identified a heterozygous NF1 frameshift variant (c.3322dup p.(Thr1108AsnfsTer9)), predicted to result in a premature termination codon and classified as pathogenic according to American College of Medical Genetics and Genomics (ACMG) / Association for Molecular Pathology (AMP) criteria. Postoperatively, metanephrine levels normalized and blood pressure remained stable. Pheochromocytoma in patients with NF1 may present with hypotension and isolated biochemical abnormalities. This possibility should be considered in the appropriate clinical context. The identified NF1 variant contributes to the existing literature on NF1-associated tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.